Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
19 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
A patient from hospital and clinic as well
Adult male or female patient of over 19 years of age
A patient diagnosed with knee osteoarthritis
A patient who has been informed of the purpose, method of the study and signed the written informed consent form.
A patient who shows hypersensitive reaction to the Synovian® Inj. or to the ingredients of Synovian® Inj.
A patient with infection at the joint
A patient with skin infection or skin disease at the injection area
A patient diagnosed with osteoarthritis with the Kellgren & Lawrence Grade IV in X-ray within 12 months before enrollment of this study.